Samantha G Farris1, Jason D Robinson2, Michael J Zvolensky3, Julianna Hogan4, Vance Rabius5, Paul M Cinciripini6, Maher Karam-Hage7, Janice A Blalock8. 1. University of Houston, Department of Psychology, Houston, TX 77024, United States; Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, RI 02906, United States. Electronic address: sgfarris@uh.edu. 2. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: jdrobinson@mdanderson.org. 3. University of Houston, Department of Psychology, Houston, TX 77024, United States; The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: mjzvolen@central.uh.edu. 4. Michael E. DeBakey VA Medical Center, Houston, TX 77030, United States. Electronic address: jbdhogan@gmail.com. 5. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: VARabius@mdanderson.org. 6. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: pcinciri@mdanderson.org. 7. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: maherkaram@mdanderson.org. 8. The University of Texas MD Anderson Cancer Center, Department of Behavioral Science, Houston, TX 77030, United States. Electronic address: jablaloc@mdanderson.org.
Abstract
OBJECTIVE: Little is known about factors associated with smoking cessation in cancer patients. This study examined the impact of panic attacks on smoking abstinence likelihood among cancer patients receiving tobacco cessation treatment. METHOD: The relationship of panic attacks to 7-day point-prevalence abstinence at mid-treatment, end of treatment, and 6-month post-end of treatment were examined among cancer patients (N=2255 patients; 50.1% female; Mage=54.9, SD=11.0) who received counseling and pharmacotherapy for smoking cessation. Panic attack history indexed by two questions from the Patient Health Questionnaire (PHQ). Point-prevalence abstinence was assessed via the Timeline Follow-Back. RESULTS: Cancer patients with a history of panic attacks, (n=493, 21.9%) relative to those without, were less likely to be abstinent at mid-treatment (OR=0.79, CI95%=0.64-0.98) and end of treatment (OR=0.72, CI95%=0.58-0.89). After adjusting for significant covariates, panic attack history remained predictive of decreased abstinence likelihood at end of treatment (OR =0.78, CI95%=0.62-0.99). CONCLUSIONS: Panic attacks may be related to poorer cessation outcome during smoking treatment among cancer patients, and may be usefully assessed and targeted for intervention.
OBJECTIVE: Little is known about factors associated with smoking cessation in cancerpatients. This study examined the impact of panic attacks on smoking abstinence likelihood among cancerpatients receiving tobacco cessation treatment. METHOD: The relationship of panic attacksto 7-day point-prevalence abstinence at mid-treatment, end of treatment, and 6-month post-end of treatment were examined among cancerpatients (N=2255 patients; 50.1% female; Mage=54.9, SD=11.0) who received counseling and pharmacotherapy for smoking cessation. Panic attack history indexed by two questions from the Patient Health Questionnaire (PHQ). Point-prevalence abstinence was assessed via the Timeline Follow-Back. RESULTS:Cancerpatients with a history of panic attacks, (n=493, 21.9%) relative to those without, were less likely to be abstinent at mid-treatment (OR=0.79, CI95%=0.64-0.98) and end of treatment (OR=0.72, CI95%=0.58-0.89). After adjusting for significant covariates, panic attack history remained predictive of decreased abstinence likelihood at end of treatment (OR =0.78, CI95%=0.62-0.99). CONCLUSIONS:Panic attacks may be related to poorer cessation outcome during smoking treatment among cancerpatients, and may be usefully assessed and targeted for intervention.
Authors: Russell Noyes; Caroline P Carney; Stephen L Hillis; Laura E Jones; Douglas R Langbehn Journal: Psychosomatics Date: 2005 Nov-Dec Impact factor: 2.386
Authors: Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael F Fleming; Amy A Bittrich; Jennifer L Brown; Cathlyn J Leitzke; Mark E Zehner; Michael C Fiore; Timothy B Baker Journal: J Consult Clin Psychol Date: 2010-02
Authors: Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006
Authors: Allison J Carroll; Anna K Veluz-Wilkins; Sonja Blazekovic; Ravi Kalhan; Frank T Leone; E Paul Wileyto; Robert A Schnoll; Brian Hitsman Journal: Psychooncology Date: 2017-08-04 Impact factor: 3.894
Authors: Jaimee L Heffner; Kristin E Mull; Noreen L Watson; Jennifer B McClure; Jonathan B Bricker Journal: Drug Alcohol Depend Date: 2018-10-10 Impact factor: 4.492
Authors: Catherine R Ayers; Jaimee L Heffner; Cristina Russ; David Lawrence; Thomas McRae; A Eden Evins; Robert M Anthenelli Journal: Depress Anxiety Date: 2019-12-18 Impact factor: 6.505